YieldMax HIMS Option Income Strategy ETF(HIYY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HIYY YieldMax HIMS Option Income Strategy ETF

Closed Independence Day 07-02 16:00:00 EDT

16.90

-0.47

-2.73%

盘后16.90

+0.000.00%

18:44 EDT

High17.41	Low16.76	Vol76.02K
Open17.41	D1 Closing17.37	Amplitude3.74%
Mkt Cap10.56M	Tradable Cap10.56M	Total Shares625.00K
T/O1.29M	T/O Rate12.16%	Tradable Shares625.00K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HIYY","market":"US","secType":"STK","nameCN":"YieldMax HIMS Option Income Strategy ETF","latestPrice":16.9,"timestamp":1783022400000,"preClose":17.3739,"halted":0,"volume":76020,"hourTrading":{"tag":"盘后","latestPrice":16.9,"preClose":16.9,"latestTime":"18:44 EDT","volume":18,"amount":304.2,"timestamp":1783032262266,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.027276547004414696,"floatShares":625000,"shares":625000,"eps":0,"marketStatus":"Closed Independence Day","change":-0.4739,"latestTime":"07-02 16:00:00 EDT","open":17.41,"high":17.41,"low":16.76,"amount":1288596.47112,"amplitude":0.037412,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":17.3739,"sharesOutstanding":125000,"nav":17.54,"aum":10962500,"dividendRate":0.830846,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":16.3,"preClose":17.3739,"latestTime":"08:16 EDT","volume":6386,"amount":103888.36119799998,"timestamp":1782994613385,"change":-1.0739,"changeRate":-0.061811,"amplitude":0.062162},"postHourTrading":{"tag":"盘后","latestPrice":16.9,"preClose":16.9,"latestTime":"18:44 EDT","volume":18,"amount":304.2,"timestamp":1783032262266,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.230886,"impliedVol":0.5012,"impliedVolPercentile":0.5556},"requestUrl":"/m/hq/s/HIYY/wiki","defaultTab":"wiki","newsList":[{"id":"2648503293","title":"Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648503293","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648503293?lang=en_us&edition=fundamental","pubTime":"2026-07-02 14:41","pubTimestamp":1782974499,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) is back in focus after securing a $400 million financing arrangement with JPMorgan Chase Bank. This move improves liquidity while regulatory scrutiny of its peptide ambitions intensifies.\nSee our latest analysis for Hims & Hers Health.\nAt a share price of $37.57, Hims & Hers Health has seen strong short term momentum, with a 1 month share price return of 35.34% and 90 day share price return of 96.29%, while the 1 year total shareholder return declined 20.84% but the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-secures-400-million-financing-is-the-u","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-secures-400-million-financing-is-the-u","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","HIMZ","HMYY","HIMS","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648256529","title":"Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648256529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648256529?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:03","pubTimestamp":1782939813,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN433146:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMY","HMYY","BK4196","HIMS","HIMZ","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648529254","title":"Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase","url":"https://stock-news.laohu8.com/highlight/detail?id=2648529254","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648529254?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:03","pubTimestamp":1782939803,"startTime":"0","endTime":"0","summary":"Hims & Hers signs USD 400 million receivables purchase facility with JPMorgan ChaseHims & Hers subsidiaries XeCare, Apostrophe Pharmacy entered a Master Receivables Purchase Agreement with JPMorgan on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL96VZhv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2054465674.USD","LU0211326755.USD","LU0211327993.USD","HIYY","LU1366192091.USD","LU2237443465.HKD","LU2023250330.USD","LU2237443622.USD","LU0256863902.USD","LU2462157665.USD","IE0034235295.USD","IE00B775SV38.USD","LU0859254822.USD","IE00BWXC8680.SGD","LU2237443549.SGD","LU2746668461.USD","IE00BDRTCR15.USD","LU2756315318.SGD","BK4550","LU1894683264.USD","LU2381873111.SGD","LU1116320737.USD","LU1244550577.SGD","LU2756315664.SGD","LU0496365809.HKD","LU0820561818.USD","LU0323591593.USD","LU1974910355.USD","LU0267386448.USD","LU0976567544.SGD","LU2746668974.SGD","LU0208291251.USD","LU0211331839.USD","BK4504","LU1551013342.USD","LU1244550221.USD","IE00BJLML261.HKD","LU0149725797.USD","LU1162221912.USD","LU1496350502.SGD","IE00BJTD4V19.USD","LU1670627923.USD","LU0689472784.USD","BK4196","SG9999002224.SGD","HIMS","BK4566","LU1363072403.SGD","LU1668664300.SGD","LU2213496289.HKD","IE000M9KFDE8.USD","LU0203347892.USD","IE00B1XK9C88.USD","LU2237443978.SGD","LU0048584097.USD","LU0251132253.USD","LU1064131342.USD","LU2244417387.USD","LU0256863811.USD","BK4585","LU0882574139.USD","LU2264538146.SGD","BK4533","LU2430703251.USD","BK4588","LU2106854487.HKD","JPX","BK4516","IE00BZ1G4Q59.USD","LU2023250843.SGD","LU2505996509.AUD","LU2242649171.HKD","LU0345770993.USD","IE00BDCRKT87.USD","LU0106261372.USD","IE00B3S45H60.SGD","LU0320765646.SGD","LU0964807845.USD","LU0640476718.USD","LU0868494708.USD","LU1032466523.USD","LU2236285917.USD","LU1267930490.SGD","IE0034235188.USD","IE00BKDWB100.SGD","LU1629891620.HKD","LU0820562030.AUD","LU2552382132.HKD","BK4534","BK4581","LU0106831901.USD","LU1084165304.USD","LU1116320901.HKD","LU1670628061.USD","JPO","LU0238689110.USD","LU0787776722.HKD","LU0942090050.USD","BK4207","LU1894683348.USD","LU0187121727.USD","LU0971096721.USD","LU1914381329.SGD","LU0265550946.USD","IE00BLSP4239.USD","LU0211328371.USD","IE00B1BXHZ80.USD","LU2505996681.GBP","LU1988902786.USD","LU2237443895.HKD","IE00BFXG1179.USD","LU0215105999.USD","LU0345769631.USD","LU0820561909.HKD","LU0310799852.SGD","LU0320765489.SGD","LU0234572021.USD","SG9999002232.USD","LU2592432038.USD","LU0203345920.USD","LU1244550494.USD","LU0170899867.USD","LU2357305700.SGD","LU0417517546.SGD","LU1720051017.SGD","LU1261432733.SGD","LU2357627491.SGD","HIMZ","LU1548497426.USD","LU2237443382.USD","LU2456880835.USD","LU2023250504.SGD","LU2211815571.USD","LU2417539215.USD","JPM","IE00BLSP4452.SGD","LU2430703095.HKD","LU0070302665.USD","IE00BJTD4N35.SGD","LU2430703178.SGD","LU0006306889.USD","LU0345769128.USD","IE00BKVL7J92.USD","LU1280957306.USD","LU1917777945.USD","LU0943347566.SGD","IE0034235303.USD","LU1551013425.SGD","IE00BN8TJ469.HKD","LU1496350171.SGD","LU0868494617.USD","LU1720051108.HKD","IE00BYXW3230.USD","HMYY","HIMY","JPMO","LU0345770308.USD","LU1119994496.HKD","LU0265550359.USD","LU2552382215.SGD","LU1145028129.USD","LU2552382058.USD","IE00BBT3K403.USD","LU0211326839.USD","LU0234570918.USD","IE00BHPRN162.USD","LU0683600562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648540507","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2648540507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648540507?lang=en_us&edition=fundamental","pubTime":"2026-07-02 01:19","pubTimestamp":1782926397,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF  adding 0.4%.The iShares Biotechnology ETF  was fractionally higher.In corporate news, Hims & Hers Health  shares jumped past 8% after BofA Securities lifted the company's price target to $36 from $25, while keeping its neutral rating.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","LABU","BK4585","XBI","XLV","BK4581","IBB","LU0029874061.USD","HIMZ","BK4588","HIYY","HIMY","BK4137","HCSG","HMYY","HIMS","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648940549","title":"BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2648940549","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648940549?lang=en_us&edition=fundamental","pubTime":"2026-07-01 22:06","pubTimestamp":1782914817,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) has an average rating of Hold and mean price target of $29.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","HMYY","HIMZ","HIMS","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648543734","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2648543734","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648543734?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:52","pubTimestamp":1782910320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 01, 2026 08:52 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HMYY","HIMZ","HIMS","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648154824","title":"HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2648154824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648154824?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:16","pubTimestamp":1782908218,"startTime":"0","endTime":"0","summary":"Shares of Hims & Hers ($HIMS) rose in pre-market trading after receiving a new Street-high price target of $40. Canaccord Genuity analyst Maria Rip...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMY","HIMZ","BK4196","HIMS","HIYY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648510005","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648510005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648510005?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:01","pubTimestamp":1782907265,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims &...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","HIMS","HMYY","BK4139","LU0889565916.HKD","ORKA","LU1061106388.HKD","IE0002141913.USD","LU1571399168.USD","HIMZ","BK4566","LU2089984988.USD","BK4533","LU0122379950.USD","LU0289739699.SGD","BK4196","LU2242652126.USD","BK4588","IE0009355771.USD","BK4581","HIMY","LU1057294990.SGD","LU0868494617.USD","IE00B2B36J28.USD","AMGN","04332","BK4534","LU1023059063.AUD","HIYY","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4599","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0109394709.USD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1983299246.USD","LU2112291526.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648517550","title":"Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2648517550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648517550?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:05","pubTimestamp":1782903937,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nAZN4T5E2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HMYY","HIMS","HIMY","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646369411","title":"Moderately bullish activity in Hims and Hers Health with shares up 5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646369411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646369411?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:55","pubTimestamp":1782489309,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares up $1.74, or 5.3%, near $34.45. Options volume running well above average w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-5-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-5-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMZ","HMYY","HIMS","HIMY","BK4196","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879143","title":"Analysis-hims' Obesity Drug Business May Get Boost as Employers Drop Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879143","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646879143?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:00","pubTimestamp":1782381600,"startTime":"0","endTime":"0","summary":"CORRECTED-ANALYSIS-Hims' obesity drug business may get boost as employers drop coverageCorrects paragraph 15 to reflect that Hims & Hers is one of the most volume-producing of Novo’s partners, and not","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL1N42O14W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESCA","IE0002270589.USD","IE00B19Z3581.USD","LU0289739699.SGD","BK4588","HIMS","IE00B19Z3B42.SGD","BK4585","LU0058720904.USD","BK4190","LU1059921491.USD","HIYY","TFC","HIMY","HMYY","LU2237438978.USD","LU1261432733.SGD","BK4211","CI","HIMZ","IE00BSNM7G36.USD","BK4196","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645852702","title":"Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2645852702","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645852702?lang=en_us&edition=fundamental","pubTime":"2026-06-24 06:40","pubTimestamp":1782254411,"startTime":"0","endTime":"0","summary":"Hims & Hers Health CFO Oluyemi Okupe sold 18,197 Class A shares on June 22 at an average $34.03.He exercised options for 6,376 shares at $5.01 the same day.Directly held stake ended at 284,321 shares; an additional 7,853 shares were held indirectly via a trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL64Qc8G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMS","HIMZ","BK4196","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644103924","title":"Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644103924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644103924?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:45","pubTimestamp":1781815510,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Hims and Hers Health (HIMS), with shares up $3.67, or 11.49%, near $35.55. Options volume more than double the d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-11-49-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-11-49-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HMYY","HIMS","HIMZ","HIYY","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644380030","title":"Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644380030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644380030?lang=en_us&edition=fundamental","pubTime":"2026-06-19 02:15","pubTimestamp":1781806500,"startTime":"0","endTime":"0","summary":"Health is wealth goes the saying. Now it's an investment opportunity, too.The consumerization of healthcare is nothing new, but the pandemic turbocharged its widespread adoption. From telehealth appointments to digital patient portals and wearable trackers, many people began to treat their health like any other retail experience -- whether it's walking into a CVS Health MinuteClinic after doing some shopping, or trying  to estimate the out-of-pocket price for procedures with cost-estimator tools.The upshot is that longevity, i.e. not only living longer but being healthy for longer, could be big business for healthcare companies. TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion, with beneficiaries spanning companies making biological breakthroughs to those using artificial intelligence.\"Tools to measure and screen health status--across blood-based testing, imaging, and wearable--have advanced meaningfully,\" writes lead analyst Da","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU0211331839.USD","LU2089984988.USD","GB00BDT5M118.USD","LU2324357040.USD","LU0345770993.USD","LU2237957902.USD","DXCM","CVS","SGXZ41872573.SGD","BK4550","SG9999002224.SGD","LU1721429741.USD","BK4535","LU0963586101.USD","OWLT","BK4121","HIYY","LU2133065610.SGD","LU0354030511.USD","LU0106261612.USD","BTMD","LU0170899867.USD","BK4167","HIMY","LU0053671581.USD","GH","LU1023059063.AUD","IE0002141913.USD","LU0006061336.USD","LU0289739699.SGD","BFLY","IE00BMPRXN33.USD","LU0868494617.USD","LU1914381329.SGD","BK4581","LU0058720904.USD","IE00BKVL7J92.USD","LU2065169927.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU2095319765.USD","LU0162691827.USD","LU1571399168.USD","BK4585","LU0208291251.USD","BK4568","BK4082","LU2112291526.USD","LU2210149790.SGD","LU2065731478.USD","BK4567","LU2211815571.USD","LU0432979614.USD","LU0320765489.SGD","BK4504","SG9999004303.SGD","BK4548","LU1061106388.HKD","BK4007","LU0390134368.USD","LU2125909593.SGD","NTRA","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU2065170008.USD","TDOC","LU1988902786.USD","LU2237957811.SGD","MYGN","LU0070302665.USD","HIMZ","ABT","LU0266013472.USD","LU0882574055.USD","BK4216","LU1923622614.USD","LU2468319806.SGD","LU1989763690.USD","HMYY","LU0354030438.USD","IE00BMPRXR70.SGD","BK4592","LU0114720955.EUR","IE00B4R5TH58.HKD","LU1323610961.USD","LU2065171402.SGD","LU1057294990.SGD","BK4551","IE0009355771.USD","BK4534","LU0122379950.USD","BK4139","IE00BFTCPJ56.SGD","IE0002270589.USD","LU0234572021.USD","QTRX","LU0345770308.USD","LU1989763427.SGD","LU0012050646.USD","BK4209","LU1699723380.USD","LU1861559042.SGD","CAVA","IE00BZ1G4Q59.USD","BK4566","IE00BJT1NW94.SGD","LU1064131342.USD","LU2065171311.SGD","LU2433249047.HKD","BK4588","LU1861558580.USD","LU1721429402.USD","BK4533","LU2125909247.SGD","LU0061475181.USD","LU1983299246.USD","LU2264538146.SGD","IE00B19Z3B42.SGD","LU2210150020.SGD","LU0072461881.USD","BK4196","LU1691799644.USD","PLNT","SGXZ23171101.USD","IE00BSNM7G36.USD","HIMS","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644681087","title":"Hims & Hers Health Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2644681087","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644681087?lang=en_us&edition=fundamental","pubTime":"2026-06-18 23:49","pubTimestamp":1781797740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 18, 2026 11:49 ET (15:49 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS","HIMY","HMYY","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644877042","title":"U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis","url":"https://stock-news.laohu8.com/highlight/detail?id=2644877042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644877042?lang=en_us&edition=fundamental","pubTime":"2026-06-18 15:14","pubTimestamp":1781766857,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Datadog, Jabil, PrologisJune 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Datadog, Jabil an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nL4N42Q0IZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG","BTSG","DOGD","EGP","CME","CPT","TECH","BIIB","HMYY","MUD","LU0342679015.USD","EFX","EXR","KMX","PAYO","PK","LU2236285917.USD","MAA","GRDN","EFSC","PEP","NRIX","LU2211815571.USD","LXP","FR","INDV","LU1861215975.USD","MULL","BDSX","HIMY","MUU","ESS","EPRT","NUE","HIMZ","AHR","FROG","HIMS","CAG","AJG","BXP","HIYY","ILMN","JBL","INTU","DDOG","MU","ANDE","DUK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644977749","title":"Barclays Keeps Their Buy Rating on Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644977749","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644977749?lang=en_us&edition=fundamental","pubTime":"2026-06-18 14:27","pubTimestamp":1781764020,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo maintained a Buy rating on Hims & Hers Health today and set a price target of $39.00. Santangelo covers the Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HMYY","HIMS","HIMZ","BK4196","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644727968","title":"Hims & Hers CTO Mohamed Elshenawy disposes of USD 1.42 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644727968","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644727968?lang=en_us&edition=fundamental","pubTime":"2026-06-18 06:51","pubTimestamp":1781736670,"startTime":"0","endTime":"0","summary":"Hims & Hers Health CTO Mohamed Elshenawy acquired 282,597 Class A shares on June 15 via RSU vesting and settlement.Issuer withheld 151,534 shares at USD 30.17 to cover tax obligations tied to the vesting.Elshenawy sold 30,040 shares on June 17 at USD 31.5, leaving 101,023 shares beneficially owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL4nYYlx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CTO Mohamed Elshenawy disposes of USD 1.42 million in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMY","HIMZ","HMYY","BK4196","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644268147","title":"Hims & Hers price target raised to $39 from $29 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2644268147","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644268147?lang=en_us&edition=fundamental","pubTime":"2026-06-18 02:55","pubTimestamp":1781722542,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Hims & Hers (HIMS) to $39 from $29 and keeps an Overweight rating on the shares. A combination of weight...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hims-hers-price-target-raised-to-39-from-29-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hims-hers-price-target-raised-to-39-from-29-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HIMZ","HIYY","HIMY","HMYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760359","title":"Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760359?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:19","pubTimestamp":1781641140,"startTime":"0","endTime":"0","summary":"That buzzy peptide market that Hims & Hers wants in on could be worth close to $2.2 billion next year for the telehealth industry, according to a new estimate. And the amount for Hims & Hers: $440 million, or about a fifth of the total.The numbers, from investment bank Leerink Partners, are based on sales estimates for seven peptides that a Food and Drug Administration panel will review in late July.Some peptides -- the building blocks of protein -- are already approved by the FDA for use in prescription weight-loss drugs like Ozempic and Wegovy.But the Leerink estimates are focused on peptides geared toward \"wellness-minded consumers,\" which have grown in popularity on social media for uses like healing injuries and promoting longevity. They often are taken by injection.This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HMYY","HIMS","HIMY","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0662},{"period":"1month","weight":0.1252},{"period":"3month","weight":0.2941},{"period":"6month","weight":-0.3217},{"period":"1year","weight":-0.6507},{"period":"ytd","weight":-0.3135}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"ARCA","name":"YieldMax HIMS Option Income Strategy ETF","nameEN":"YieldMax HIMS Option Income Strategy ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"YieldMax HIMS Option Income Strategy ETF(HIYY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest YieldMax HIMS Option Income Strategy ETF(HIYY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"YieldMax HIMS Option Income Strategy ETF,HIYY,YieldMax HIMS Option Income Strategy ETF股票,YieldMax HIMS Option Income Strategy ETF股票老虎,YieldMax HIMS Option Income Strategy ETF股票老虎国际,YieldMax HIMS Option Income Strategy ETF行情,YieldMax HIMS Option Income Strategy ETF股票行情,YieldMax HIMS Option Income Strategy ETF股价,YieldMax HIMS Option Income Strategy ETF股市,YieldMax HIMS Option Income Strategy ETF股票价格,YieldMax HIMS Option Income Strategy ETF股票交易,YieldMax HIMS Option Income Strategy ETF股票购买,YieldMax HIMS Option Income Strategy ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"YieldMax HIMS Option Income Strategy ETF(HIYY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest YieldMax HIMS Option Income Strategy ETF(HIYY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction